The treatment of nonartheritic anterior ischemic optic neuropathy by subtenon methylprednisolo
Not Applicable
- Conditions
- on artritic anterior ischemic opthic neropathy.Ischaemic optic neuropathy
- Registration Number
- IRCT138809182833N1
- Lead Sponsor
- Vise chanceller for research, Isfahan University of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
recent onset of non arthritic anterior ischemic optic neuropathy, history of acute visual loss, optic disc edema, afferent papillary defect, andangiographic picture, no apparent other ocular or systemic disease related to the acute visual loss
Exclusion criteria: presence of IOP of more than 21 mmhg, history of glaucoma, ocular hypertention, abnormal visual field in the sound eye, high ESR, any additional intervention during the study.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Visual acuity. Timepoint: before the intervention and at 2 weeks, 4 weeks, 6 weeks, and 8 weeks steps of follow up after the intervention. Method of measurement: Snellen chart.;Optic disc edema. Timepoint: before the intervention and at 2 weeks, 4 weeks, 6 weeks, and 8 weeks steps of follow up after the intervention. Method of measurement: Slit lamp ophthalmoscopy.
- Secondary Outcome Measures
Name Time Method Plotting the visual field. Timepoint: before the intervention and at 8 weeks steps of follow up after the intervention. Method of measurement: Humphry Automated perimeter.